Epstein Secrets

CIRCLE.11JCICER. GA 30084-6S02 Laboratocy Duccior ANDREW N YOUNG.MD.PIID.CLIA: I I D0255931 MI QUIST DIA

with diabetes plus 1 major ASCVD risk factor, treating to a non-HDL-C goal of <100 mg/dL (LDL-C of <70 mg/dL) is considered a therapeutic option. HS CRP 1.3 Average relative cardiovascular risk according to AHA/CDC guidelines. For ages >17 hs-CRP mg/L <1.0 1.0-3.0 3.1-10.0 >10.0 Years: Risk

RCLE. IIICICER GA 30014.6802 Laboratory Director. ANDREW N YOUNG.AID.PHD.CLIA: 1100255931 MI QUEST DIAGN

with diabetes plus 1 major ASCVD risk factor, treating to a non-HDL-C goal of <100 mg/dL (LDL-C of <70 mg/dL) is considered a therapeutic option. HS CRP 1.1 <5.0 (talc) <130 mg/dL (talc) mg/L The above test was performed; the specimen was lipemic. Average relative cardiovascular risk according

CIRCLE.11JCICER. GA 30084-6S02 laboratory Dutch:. ANDREW N YOUNG.MD.PIID.CLIA: 1100255931 MI QUEST DIAGN

with diabetes plus 1 major ASCVD risk factor, treating to a non-HDL-C goal of <100 mg/dL (LDL-C of <70 mg/dL) is considered a therapeutic option. HS CRP 1.2 Average relative cardiovascular risk according to AHA/CDC guidelines. For ages >17 hs-CRP mg/L <1.0 1.0-3.0 3.1-10.0 >10.0 Years: Risk